Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - Sex Differences in Obstructive Sleep Apnea “ Why it Matters, May 8, 2020, 5/8/2020 8:00:00 AM - 5/8/2023 9:00:00 AM, (We are aware that the audio on this presentation is not ideal)
Dr. Won compares the prevalence, risk factors, clinical consequences and implications for treatment and outcomes between men and women presenting with possible obstructive sleep apnea (OSA). OSA is more prevalent in men, and men are more likely to be referred for sleep studies while women are more likely to be evaluated with chemistries and neuropsychiatric testing for sleep related symptoms. Dr. Won describes structural and functional risk factors for OSA and discusses the varying patterns in REM sleep and sleep apnea among differing phenotypes. While CPAP is a very effective treatment, particularly with men, compliance is low which makes outcomes difficult to measure.
Presenter
Christine H.J. Won, MD, MS
Associate Professor of Medicine
Section of Pulmonary, Critical Care and Sleep Medicine
Yale School of Medicine
Medical Director, Yale Women™s Initiative in Sleep Health
About our presenter:
Dr. Christine Won graduated from Stanford University with her undergraduate degree and a Masters in Science in Health Epidemiology, Research and Policy. She completed her medical education at Albert Einstein College of Medicine, and her residency and fellowship training at Beth Israel in NYC and Stanford University. She is active in the American Academy of Sleep Medicine, having chaired their Sleep Breathing Disorders Committee, and having served on their Education Committee and Program Committee.
Learning Outcome(s)
Participants will be able to identify differences in clinical presentation and polysomnography phenotypes of OSA between men and women, describe the role of different pathophysiologic mechanisms on OSA phenotypes and discuss how gender differences in disease manifestation can lead to under-recognition and missed opportunities for treatment in women.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual™s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. All potential conflict(s) were resolved.
* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio.
* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Dr. Won compares the prevalence, risk factors, clinical consequences and implications for treatment and outcomes between men and women presenting with possible obstructive sleep apnea (OSA). OSA is more prevalent in men, and men are more likely to be referred for sleep studies while women are more likely to be evaluated with chemistries and neuropsychiatric testing for sleep related symptoms. Dr. Won describes structural and functional risk factors for OSA and discusses the varying patterns in REM sleep and sleep apnea among differing phenotypes. While CPAP is a very effective treatment, particularly with men, compliance is low which makes outcomes difficult to measure.
Presenter
Christine H.J. Won, MD, MS
Associate Professor of Medicine
Section of Pulmonary, Critical Care and Sleep Medicine
Yale School of Medicine
Medical Director, Yale Women™s Initiative in Sleep Health
About our presenter:
Dr. Christine Won graduated from Stanford University with her undergraduate degree and a Masters in Science in Health Epidemiology, Research and Policy. She completed her medical education at Albert Einstein College of Medicine, and her residency and fellowship training at Beth Israel in NYC and Stanford University. She is active in the American Academy of Sleep Medicine, having chaired their Sleep Breathing Disorders Committee, and having served on their Education Committee and Program Committee.
Learning Outcome(s)
Participants will be able to identify differences in clinical presentation and polysomnography phenotypes of OSA between men and women, describe the role of different pathophysiologic mechanisms on OSA phenotypes and discuss how gender differences in disease manifestation can lead to under-recognition and missed opportunities for treatment in women.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual™s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. All potential conflict(s) were resolved.
* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio.
* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.